Our previous study showed that the hyperphosphorylation of the ACAP4-binding protein ezrin was closely correlated to an invasive phenotype of clinical hepatocellular carcinomas (HCC) and poor survival in mice with HCC tumor xenografts (Chen et al., 2011). Here, EZR is linked to hepatocellular carcinoma.